surmount-1 trial tirzepatide weight loss results after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 Gastrointestinal tolerability and weight reduction

BPC-157 and similar "performance peptides" marketed for muscle recovery lack human validation despite extensive preclinical data

Many factors determine pregnancy outcomes

Its not a quick fix, but rather a tool that helps people manage their weight or diabetes over time

The new research raises hope that GLP-1 drugs could serve as a strategy for breast cancer prevention, especially among higher-risk females with overweight and obesity

One unit on a 1 ml (100-unit) insulin syringe equals 0.25 mg of GHK-Cu

Estimates suggest there are about 4 million people in the UK living with atherosclerotic cardiovascular disease, who remain at very high risk of subsequent or further heart attacks and strokes, and related deaths despite our best available treatments